Search by Journal

  • HOME 
  •  >  Search by Journal
  •  >  Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Annual Meeting of Japanese Association of Cardiovascular Pharmacology

Volume 32, Issue / 2023
English Article   Japanese Article
  • Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
Japanese Article The new treatment strategy which assumed the condition of a patient elucidation and cell aging of the aging-related cardiovascular disease a target
南野徹
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 16-16, 2023.
Japanese Article An epigenetics control structure and drug discovery application of viral infections
今井由美子
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 17-17, 2023.
Japanese Article From mechanism of the atrial fibrillation chronicity to social implementation of the initiative medical care
古川哲史
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 18-18, 2023.
Japanese Article PS-1. The reactions of drugs evaluation of cardiac muscle cells derived from human iPS cells and development to a disease model
諫田泰成
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 19-19, 2023.
Japanese Article PS-2. Circulation control structure by the multiple organs cooperation through a nerve, the immune system
藤生克仁
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 20-20, 2023.
Japanese Article PS-3. Signal transduction mechanism to control the vascular formation and function
福原茂朋
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 21-21, 2023.
Japanese Article YG-01. A485 improved progression of heart failure of the pressure load model mouse by inhibiting HAT activity of p300
山本みずほ1), 上原渉1), 眞鍋智弘1), 船本雅文1)2), 砂川陽一1)2)3), 刀坂泰史1)2)3), 浜辺俊秀1), 清水果奈1)2), 清水聡史1), 小見山麻紀2), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 24-24, 2023.
Japanese Article YG-02. Examination of the inhibition mechanism by Suramin for the ST elevation at anaphylactic instruction
清水滉規, 加渡規倫, 仲田勝哉, 佐竹祐香, 加納誠一朗
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 25-25, 2023.
Japanese Article YG-03. Blood glucose level drop effect of A484954 in the type 2 diabetes model ZFDM rat
安達航, 兒玉朋子, 大谷紘資, 岡田宗善, 山脇英之
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 26-26, 2023.
Japanese Article YG-04. A rise of Neuregulin-1 in the diabetic cardiomyopathy in expression and the physiologic significance
岩瀬奎輝, 三上義礼, 大島大輔, 冨田太一郎, 赤羽悟美
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 27-27, 2023.
Japanese Article YG-05. New p300 binding protein p300 binding protein 1 promotes cardiac muscle cells enlargement
石間彩花1), 砂川陽一1)2)3), 松下優作1), 海野瑞紀1), 船本雅文1)2), 清水果奈1)2), 清水聡史1)2), 浜辺俊秀1)2)3), 刀坂泰史1)2)3), 長谷川浩二1)2)3), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 28-28, 2023.
Japanese Article YD-01. Elucidation of the role of CaMKK2 in excitement transcription linkage and the blood vessel remodeling formation
中島七海1), 鈴木良明1), 荒木正建2), 荒木喜美3), 近藤るびい1), 今泉祐治1), 山村寿男1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 29-29, 2023.
Japanese Article YD-02. The Goshajinkigan and the Ninjin'yoeito inhibited cardiac muscle cells enlargement by the Phenylephrine stimulation
Wu HANHAO1)2)3), 塚部凌輔1), 浜辺俊秀1)2)3), 清水果奈1)2), 船本雅文1)2), 川瀬裕斗1), 平子裕太1), 砂川陽一1)2)3), 刀坂泰史1)2)3), 清水聡史1)2), 小見山麻紀2), 長谷川浩二1)2), 森本達也1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 30-30, 2023.
Japanese Article YD-03. Elucidation of the role that L-PGDS serves as in anticancer agent sensitivity of the cancer vascular endothelium
小林唯1), 宮崎悠介1), 大森啓介1), 小林幸司2), 永田奈々恵1), 藤井渉3), 村田幸久1)2)4)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 31-31, 2023.
Japanese Article YD-04. Discovery of the oxidation LDL accumulation mechanism through CD36 to a brown adipose tissue
細見謙登1)2), 河嶋秀和3), 中野厚史4), 垣野明美1)5), 岡松優子6), 細田洋司1)5), 飯田秀博4), 沢村達也1)5)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 32-32, 2023.
Japanese Article YD-05. The vesicle derived from the culture supernatant of aging cells out of the cells induces automatic fuzzy in the heart fibroblasts
藤岡友星, 大谷紘資, 兒玉朋子, 岡田宗善, 山脇英之
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 33-33, 2023.
Japanese Article YD-06. The pulmonary vein myocardium spontaneous activity of the I group antiarrhythmic drug and effect for the ventricular muscular contraction power
日色啓仁, 濱口正悟, 行方衣由紀, 田中光
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 34-34, 2023.
Japanese Article YD-07. Comparison between L-form Ca2+ channel inhibitor verapamil and antiarrhythmic action properties of Na+/Ca2+ exchange mechanism inhibitor SEA0400 for the medicamentosus long QT syndrome
川上聡士, 高田一唐, 石丸雄己, 相本恵美, 永澤悦伸, 高原章
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 35-35, 2023.
Japanese Article YD-08. The human omentin-1 administration improves the high blood pressure of obesity, the type 2 diabetes model OLETF rat
岡村勇汰1), 安達航1), 新島亮2), 兒玉朋子1), 大谷紘資1), 岡田宗善1), 山脇英之1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 36-36, 2023.
Japanese Article YD-09. Calcium densitometry technique by the light sound imaging using the calcium indicator
山本勇志, 興野大輝, 五味涼太, 庄司一郎, 村上慎吾
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 37-37, 2023.
Japanese Article YD-10. Elucidation of Ca2+ release-activated Ca2+ channel control mechanism by junctophilin 2 in rat aortic smooth muscle cells
倉田朋, 鈴木良明, 近藤るびい, 今泉裕治, 山村寿男
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 38-38, 2023.
Japanese Article YIA-01. The effect that proton pump inhibitor gives for VEGF expression
八木健太1)5), 相澤風花2)5), 新村貴博1)5), 石澤有紀3), 濱野裕章4), 合田光寛2)5), 座間味義人4)5), 石澤啓介1)2)5)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 39-39, 2023.
Japanese Article YIA-02. eEF2K inhibitor A484954 induces a diuretic effect through nitric oxide production in the spontaneously hypertensive rat
兒玉朋子1), 亀島聡2), 大谷紘資1), 岡田宗善1), 山脇英之1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 40-40, 2023.
Japanese Article YIA-03. Exhaustive analysis of the sex differences formation factor of the renal function that distinguished sex hormone, sex chromosomes
清水聡史1)2), Pornparn Kongpracha2), 杉本早穂1), 水野葵1), 宮坂政紀2), Pattama Wiriyasermkul2), 坂本多穗1), 中井雄治3), 永森收志2), 黒川洵子1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 41-41, 2023.
Japanese Article YIA-04. New pathological model development of the check point inhibitor-related myocarditis using the PD-1 knockout mouse of immunity
新村貴博1)2), 運天拡人2), 濱野裕章1)3), 内田和志2), 宮田晃志2), 合田光寛2)4), 八木健太1)2), 相澤風花2)4), 石澤有紀5), 座間味義人2)3), 石澤啓介1)2)4)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 42-42, 2023.
Japanese Article YIA-05. Comparison of the effect of the cigarette smoke extract of the conventional ceremony to give to the automatic beating rate of rat cardiac muscle cells and contractile function and the calcium change in cells and heating type cigarette
安田純平1), 松村早季子1), 堀之内孝広2), 西谷 (中村) 友重1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 43-43, 2023.
Japanese Article YIA-06. Role of super sulfur molecules in the ischemic myocardium
下田翔1)2), 西村明幸2), 西山和宏1), 加藤百合1), 赤池孝章3), 守田匡伸3), 西田基宏1)2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 44-44, 2023.
Japanese Article O-01. Localized abnormality of insulin signal-dependent Cav1.2 and Jph2 in the ventricular cardiac muscle cells of the diabetic cardiomyopathy model mouse
三上義礼, 冨田太一郎, 大島大輔, 赤羽悟美
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 46-46, 2023.
Japanese Article O-02. Good use of various RyR2 mutation mice for the effect inspection of the antiarrhythmic drug
呉林なごみ1), 児玉昌美1), 村山尚1), 杉原匡美2), 小西真人1), 三浦綾3), 西尾元3), 井上 - 上野由紀子4), 井上高良4), 野口悟4), 櫻井隆1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 47-47, 2023.
Japanese Article O-03. The molecular mechanism that YAP activated by acute pressure minus number stimulation aggravates myocardial glycolysis system metabolism
柏原俊英1), 中原努1), 佐渡島純一2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 48-48, 2023.
Japanese Article O-04. The elucidation of the pressure reception reflection reply control structure by the Zn2+ inflow through the TRPC6 channel and treatment application for the heart failure
西山和宏1), 古本裕香1), 大久保礼真1), 小田紗矢香2), 西村明幸3), 加藤百合1), 西田基宏1)2)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 49-49, 2023.
Japanese Article O-05. Norepinephrine release in the ischemic inducible myocardium and effect of the nicorandil on ischemic ventricular arrythmia
小原幸, 鳥羽裕恵, 中田徹男
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 50-50, 2023.
Japanese Article O-06. Role of the multifunctional protease in the octopus key point syndrome
大野美紀子, 西清人, 西英一郎
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 51-51, 2023.
Japanese Article O-07. The SGLT2 inhibitor inhibits the atrial fibrillation-induced sthenia in the high fat diet-induced obese mice model
澤野達哉1), 三明淳一朗1), アグンクルニアワンプリヨノ1), 岡村昌宏2), 友森匠也2), 高見亜以子2), 長田佳子1), 今村武史1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 52-52, 2023.
Japanese Article O-08. The Cnot3 loss promotes arteriosclerosis progress with interferon gamma
安健博1), 山口智和1)2), 星崎みどり2)3), 矢萩理沙1), 今井由美子3), 久場敬司1)2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 53-53, 2023.
Japanese Article O-09. Platelet agglutinating capacity in the quinonoid dihydropteridine reductase loss mouse
菅沼由唯1), 狩野泰輝1), 池本和久1), 一瀬 - 鷲見千穂1), 一瀬宏2), 近藤一直1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 54-54, 2023.
Japanese Article O-10. It is an effect of becoming it Drp1 glutathione for mitochondrial excessive division caused by sulfur metabolic disorders and the cardiac muscle cells aging
西村明幸1), Tang Xiaokang1), Hengphasatporn Kowit2), 西山和宏3), 加藤百合3), 重田育照2), 西田基宏1)3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 55-55, 2023.
Japanese Article O-11. The hepatocellular null D rye gin controls brown adipose tissue heat production
西清人, 岩崎広高, 大野美紀子, 西英一郎
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 56-56, 2023.
Japanese Article O-12. The in vivo electric pharmacologic effect of the proton pump inhibitor: Heart safety reactions of drugs evaluation using the halothane anesthesia dog model
後藤愛, 神林隆一, 中瀬古 (泉) 寛子, 武井義則, 杉山篤
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 57-57, 2023.
Japanese Article O-13. The effect that active metabolite cetirizine of antihistamine hydroxyzine and enantiomer levocetirizine give for a ventricular repolarizing phase
永澤悦伸, 清水美希, 篠崎達朗, 相本恵美, 高原章
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 58-58, 2023.
Japanese Article O-14. Examination of the peripheral circulatory disorder improvement effect in the TRPC6 channel inhibition
加藤百合1), 冨田拓郎2), 島内司1)2), 酒田康介1), 西山和宏1), 西村明幸2), 岩本隆宏3), 森泰生4), 西田基宏1)2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 59-59, 2023.
Japanese Article O-15. The perinatal hypoxia deteriorates the condition of a patient of the pulmonary hypertension model rat
西村有平1), 大下裕法2)3), 澤田博文2), 三谷義英2), 坪谷尚季2), Kabwe Jane2), 丸山淳子4), Yusuf Ali5), 伊藤弘将5), 岡本隆二5), 大槻祥一郎2), 淀谷典子2), 大橋啓之2), 大矢和伸2), 小林裕子6), 小林一成6), 土肥薫5), 齋藤伸治3), 丸山一男7), 平山雅浩2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 60-60, 2023.
Japanese Article O-16. Tumor enhancement depressant action by the macrophage englobement function reinforcement of the VIP inhibitor
西山成, 北田研人, ラフマンアサダ, キッキュルッシュワラント
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 61-61, 2023.
Japanese Article O-17. The synthesis of new pantetheine derivative with the Vanin-1 inhibition and active evaluation
細畑圭子1), 米山弘樹2), 金徳男3), 宇佐美吉英2), 高井真司3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 62-62, 2023.
Japanese Article O-18. Effect of indoxyl sulfate acute measures on rat renal artery shrinkage response
松本貴之, 田口夏芽, 小澤恵介, 田口久美子, 小林恒雄
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 63-63, 2023.
Japanese Article O-19. It is the need of the angiotensin II type 1 receptor/β arrestin course in the nephrogenesis after the mammals
山田充彦1), 松岡大輔2), 川岸裕幸1), 井藤奈央子3), 長嶋洋治3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 64-64, 2023.
Japanese Article O-20. Mouse, rat, comparative study of the heart transcriptome in humans
小林大礎1), 岡本洋介1), 岡田大瑚2), 尾野恭一1), 石井邦明3)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 65-65, 2023.
Japanese Article O-21. β arrestin bias AT1R agonist improves the preweaning vital prognosis of the human congenital expansion cardiomyopathy mouse
川岸裕幸1)2), 冨田 (沼賀) 拓郎2), 中田勉3), 山田充彦2)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 66-66, 2023.
Japanese Article O-22. The mTOR inhibitor everolimus inhibits doxorubicin-induced cardiomyocyte apoptosis by inducing mitophagy
菅野秀一, 蓬田伸, 原明義
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 67-67, 2023.
Japanese Article O-23. About a role of transcription factor NR4A1 in the vascular smooth muscle cell death by the extension stimulation in imitation of sudden high blood pressure
趙晶, 中平毅一, 京谷陽司, 吉栖正典
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 68-68, 2023.
Japanese Article O-24. The effect that indoxyl sulfate chronic exposure gives for a vascular endothelium function
中川恵輔1), 戸田成美1), 小渕修平2), 田和正志1), 大喜多守1)
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 69-69, 2023.
Japanese Article O-25. Participation of the Rho protein in the myosin light chain phosphorylation in the early stage of the vascular endothelial cells barrier disorder and the cells marginal region localization of the actin bundle
平野勝也, 平野真弓
Annual Meeting of Japanese Association of Cardiovascular Pharmacology 32: 70-70, 2023.
▲